Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Ironwood Pharmaceuticals Inc’s stock clocked out at $0.60, down -5.13% from its previous closing price of $0.63. In other words, the price has decreased by -$5.13 from its previous closing price. On the day, 4.33 million shares were traded.
Ratios:
To gain a deeper understanding of IRWD’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 0.89 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1.24. For the most recent quarter (mrq), Quick Ratio is recorded 3.34 and its Current Ratio is at 3.34.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 16 ’25 when MCCOURT Thomas A sold 13,353 shares for $0.58 per share. The transaction valued at 7,745 led to the insider holds 1,147,281 shares of the business.
Gaskins Tammi L sold 2,563 shares of IRWD for $1,487 on May 16 ’25. The Chief Commercial Officer now owns 242,596 shares after completing the transaction at $0.58 per share. On May 19 ’25, another insider, MCCOURT Thomas A, who serves as the Officer of the company, bought 14,661 shares for $0.59 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.31.
Stock Price History:
Over the past 52 weeks, IRWD has reached a high of $7.11, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is -36.15%, while the 200-Day Moving Average is calculated to be -79.74%.
Shares Statistics:
A total of 161.81M shares are outstanding, with a floating share count of 156.14M. Insiders hold about 3.51% of the company’s shares, while institutions hold 96.54% stake in the company.
